2,2-bis(4-glycidyloxyphenyl)propane has been researched along with t 0070907 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, G; Jiang, H; Liu, H; Liu, Z; Luo, X; Shen, X; Ye, F; Zhu, W | 1 |
| Bright, JJ; Johnson, C; Muthian, G; Raikwar, HP; Rajasingh, J | 1 |
| Bright, JJ; Johnson, CN; Muthian, G; Raikwar, HP; Rajasingh, J | 1 |
| Barton, S; Harris, G; Morales, VM; Nakajima, A; Osawa, E; Saubermann, LJ; Schaefer, KL; Takahashi, H | 1 |
| Bright, JJ; Chearwae, W; Mo, C | 1 |
5 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and t 0070907
| Article | Year |
|---|---|
Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
Topics: Computer Simulation; Dipeptides; Drug Design; Models, Chemical; Models, Molecular; Molecular Structure; PPAR gamma; Stereoisomerism; Structure-Activity Relationship; Tryptophan | 2008 |
PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
Topics: Animals; Benzamides; Benzhydryl Compounds; Cell Proliferation; Demyelinating Diseases; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Drug Interactions; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Epoxy Compounds; Female; Glycoproteins; Inflammation; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; PPAR gamma; Pyridines; Th1 Cells; Thymidine; Time Factors; Tritium | 2005 |
PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Topics: Animals; Antigens; Benzamides; Benzhydryl Compounds; Cell Differentiation; Cell Proliferation; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Epoxy Compounds; Female; Immunologic Factors; Inflammation; Interferon-gamma; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; PPAR gamma; Prostaglandin D2; Pyridines; Th1 Cells; Thiazolidinediones | 2006 |
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
Topics: Amino Acid Chloromethyl Ketones; Anilides; Animals; Apoptosis; Benzamides; Benzhydryl Compounds; Caco-2 Cells; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Shape; Colorectal Neoplasms; Dose-Response Relationship, Drug; Epoxy Compounds; HT29 Cells; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; PPAR delta; PPAR gamma; Proteasome Endopeptidase Complex; Pyridines; Tubulin; Xenograft Model Antitumor Assays | 2007 |
PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzhydryl Compounds; Cell Differentiation; Embryonic Stem Cells; Epoxy Compounds; Leukemia Inhibitory Factor; Mice; Phosphorylation; PPAR gamma; Prostaglandin D2; Pyridines; Signal Transduction; STAT3 Transcription Factor; TYK2 Kinase | 2010 |